New horizons in pulmonary arterial hypertension therapies

Pulmonary arterial hypertension (PAH) is a fatal disease associated with vasoconstriction and vascular remodelling. There are three well-known pathways that contribute to the pathogenesis of PAH: endothelin, nitric oxide and prostacyclin. Treatments targeting these pathways are well established in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Galiè, Nazzareno, Ghofrani, Ardeschir-Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639192/
https://www.ncbi.nlm.nih.gov/pubmed/24293466
http://dx.doi.org/10.1183/09059180.00006613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639192/
https://www.ncbi.nlm.nih.gov/pubmed/24293466
http://dx.doi.org/10.1183/09059180.00006613

Ejemplares similares